izmir escort bayan izmir escort bodrum escort izmir escort escort izmir izmir escort antalya escort denizli escort beylikduzu gunluk kiralik daire

Good news / bad news – Pharmac’s new drug deal a bitter pill for 160 long-suffering patients

Helen Glenny 0 527
Pharmac’s decision to fund pertuzumab (trade name Perjeta) from January 2017 for New Zealanders with advanced (metastatic) HER2+ breast cancer will be good news for patients diagnosed from the New Year onwards, but is a bitter pill for the 160 Kiwis who have been deprived of this significantly life-extending drug so far and now appear to be shut out of the new agreement.
RSS
1234
-